"Impact of NOciception Level (NOL) Index Intraoperative Guidance of REmifentanil Administration on Opioid Consumption and QoR in Ambulatory Patients Undergoing LAparoscopic Cholecystectomy."
NORELACs
1 other identifier
interventional
120
1 country
1
Brief Summary
Background: Laparoscopic cholecystectomy is a common surgical procedure which constitutes the standard treatment for symptomatic gallbladder disease. Elective procedures are performed as outpatient surgery due to the minimally invasive technique, fast recovery and low complication rates. However, postoperative pain along with nausea and vomiting remains a common barrier to timely discharge from the post-anaesthesia care unit (1). The nociception level index (NOL) monitor provides a multiparametric measure of intraoperative nociception and may support individualized opioid titration (2-3). This single-center, prospective, single-blinded, randomised controlled trial investigated whether NOL-guided remifentanil administration reduces postoperative opioid consumption and improves early recovery compared with conventional clinician-guided analgesic management. Methods: 120 adult patients scheduled for outpatient laparoscopic cholecystectomy were randomised to NOL-guided or conventional remifentanil titration during general anaesthesia. The NOL monitor quantifies nociception on a 0-100 scale. The intervention group received remifentanil titrated to maintain NOL values between 10-25, whereas remifentanil titration was adjusted according to standard clinical parameters in the control group. Postoperative recovery was assessed using the QoR40-questionnaire. Statistical analyses were performed using the median test, chi-square-test, and correlation analyses, with significance defined as p\<0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFirst Submitted
Initial submission to the registry
September 2, 2026
CompletedFirst Posted
Study publicly available on registry
September 9, 2026
CompletedSeptember 14, 2026
September 1, 2026
9 months
September 2, 2026
September 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Morphine consumption
Postoperative morphine consumption in the postanasthesia care unit
From arriving in the postanasthesia care unit to discharge from the unit.
Study Arms (2)
Intervention group
ACTIVE COMPARATORGuidance of remifentanil infusion during elective laparoscopic cholecystectomy
Control Group
SHAM COMPARATORRemifentanil infusion guided by common parameters such as heart rate, blood pressure, airway pressure etc.
Interventions
Patients were still connected to the nociception level monitor, but it was covered with af cloth and therefore did not influence the nurses administration of remifentanil. The nurses titrated the remifentanil according to standard clinical parameters.
Use of a nociception level monitor to guide remifentanil infusion during elective laparoscopic cholecystectomy
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) class I-III
- Patients aged 18 years +
- Non-pregnant
- Must read and understand Danish
- Scheduled for ambulatory elective laparoscopic cholecystectomy
You may not qualify if:
- Inability to give consent
- Regular opioid use
- Chronic kidney disease (eGFR\<30)
- Intolerance to opioids, and surgery converted to open procedure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Svendborg Hospitallead
- Medtroniccollaborator
Study Sites (1)
Odense University Hospital Svendborg
Svendborg, Region Syddanmark, 5700, Denmark
Related Publications (16)
Martini CH, Boon M, Broens SJ, Hekkelman EF, Oudhoff LA, Buddeke AW, Dahan A. Ability of the nociception level, a multiparameter composite of autonomic signals, to detect noxious stimuli during propofol-remifentanil anesthesia. Anesthesiology. 2015 Sep;123(3):524-34. doi: 10.1097/ALN.0000000000000757.
PMID: 26154185BACKGROUNDRenaud-Roy E, Stockle PA, Maximos S, Brulotte V, Sideris L, Dube P, Drolet P, Tanoubi I, Issa R, Verdonck O, Fortier LP, Richebe P. Correlation between incremental remifentanil doses and the Nociception Level (NOL) index response after intraoperative noxious stimuli. Can J Anaesth. 2019 Sep;66(9):1049-1061. doi: 10.1007/s12630-019-01372-1. Epub 2019 Apr 17.
PMID: 30997633BACKGROUNDStockle PA, Julien M, Issa R, Decary E, Brulotte V, Drolet P, Henri M, Poirier M, Latulippe JF, Dorais M, Verdonck O, Fortier LP, Richebe P. Validation of the PMD100 and its NOL Index to detect nociception at different infusion regimen of remifentanil in patients under general anesthesia. Minerva Anestesiol. 2018 Oct;84(10):1160-1168. doi: 10.23736/S0375-9393.18.12720-9. Epub 2018 May 14.
PMID: 29756750BACKGROUNDShahiri TS, Richebe P, Richard-Lalonde M, Gelinas C. Description of the validity of the Analgesia Nociception Index (ANI) and Nociception Level Index (NOL) for nociception assessment in anesthetized patients undergoing surgery: a systematized review. J Clin Monit Comput. 2022 Jun;36(3):623-635. doi: 10.1007/s10877-021-00772-3. Epub 2021 Nov 16.
PMID: 34783941BACKGROUNDMeijer FS, Martini CH, Broens S, Boon M, Niesters M, Aarts L, Olofsen E, van Velzen M, Dahan A. Nociception-guided versus Standard Care during Remifentanil-Propofol Anesthesia: A Randomized Controlled Trial. Anesthesiology. 2019 May;130(5):745-755. doi: 10.1097/ALN.0000000000002634.
PMID: 30829658BACKGROUNDFuica R, Krochek C, Weissbrod R, Greenman D, Freundlich A, Gozal Y. Reduced postoperative pain in patients receiving nociception monitor guided analgesia during elective major abdominal surgery: a randomized, controlled trial. J Clin Monit Comput. 2023 Apr;37(2):481-491. doi: 10.1007/s10877-022-00906-1. Epub 2022 Aug 17.
PMID: 35976578BACKGROUNDMeijer F, Honing M, Roor T, Toet S, Calis P, Olofsen E, Martini C, van Velzen M, Aarts L, Niesters M, Boon M, Dahan A. Reduced postoperative pain using Nociception Level-guided fentanyl dosing during sevoflurane anaesthesia: a randomised controlled trial. Br J Anaesth. 2020 Dec;125(6):1070-1078. doi: 10.1016/j.bja.2020.07.057. Epub 2020 Sep 17.
PMID: 32950246BACKGROUNDOgata H, Matsuki Y, Okamoto T, Ueki R, Kariya N, Tatara T, Shigemi K, Hirose M. Intra-operative nociceptive responses and postoperative major complications after gastrointestinal surgery under general anaesthesia: A prospective cohort study. Eur J Anaesthesiol. 2021 Dec 1;38(12):1215-1222. doi: 10.1097/EJA.0000000000001505.
PMID: 33831900BACKGROUNDOgata H, Nakamoto S, Miyawaki H, Ueki R, Kariya N, Tatara T, Hirose M. Association between intraoperative nociception and postoperative complications in patients undergoing laparoscopic gastrointestinal surgery. J Clin Monit Comput. 2020 Jun;34(3):575-581. doi: 10.1007/s10877-019-00347-3. Epub 2019 Jul 1.
PMID: 31264131BACKGROUNDGornall BF, Myles PS, Smith CL, Burke JA, Leslie K, Pereira MJ, Bost JE, Kluivers KB, Nilsson UG, Tanaka Y, Forbes A. Measurement of quality of recovery using the QoR-40: a quantitative systematic review. Br J Anaesth. 2013 Aug;111(2):161-9. doi: 10.1093/bja/aet014. Epub 2013 Mar 6.
PMID: 23471753BACKGROUNDKehlet H. Postoperative pain, analgesia, and recovery-bedfellows that cannot be ignored. Pain. 2018 Sep;159 Suppl 1:S11-S16. doi: 10.1097/j.pain.0000000000001243. No abstract available.
PMID: 30113942BACKGROUNDKehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth. 1997 May;78(5):606-17. doi: 10.1093/bja/78.5.606.
PMID: 9175983BACKGROUNDJafra A, Mitra S. Pain relief after ambulatory surgery: Progress over the last decade. Saudi J Anaesth. 2018 Oct-Dec;12(4):618-625. doi: 10.4103/sja.SJA_232_18.
PMID: 30429746BACKGROUNDXiong W, Li M, Wang M, Zhang S, Yang Q. The Safety of Laparoscopic Cholecystectomy in the Day Surgery Unit Comparing with That in the Inpatient Unit: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020 Apr 28;2020:1924134. doi: 10.1155/2020/1924134. eCollection 2020.
PMID: 32420324BACKGROUNDJensen K, Kehlet H, Lund CM. Post-operative recovery profile after laparoscopic cholecystectomy: a prospective, observational study of a multimodal anaesthetic regime. Acta Anaesthesiol Scand. 2007 Apr;51(4):464-71. doi: 10.1111/j.1399-6576.2006.01251.x.
PMID: 17378786BACKGROUNDNazemroaya B, Keleidari B, Arabzadeh A, Honarmand A. Comparison of Intraperitoneal Versus Intravenous Dexamethasone on Postoperative Pain, Nausea, and Vomiting After Laparoscopic Cholecystectomy. Anesth Pain Med. 2022 Apr 30;12(2):e122203. doi: 10.5812/aapm-122203. eCollection 2022 Apr.
PMID: 35991777BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Clinical Nurse Specialist who called the patients 2 weeks after surgery
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 2, 2026
First Posted
September 9, 2026
Study Start
December 1, 2023
Primary Completion
August 31, 2024
Study Completion
September 30, 2024
Last Updated
September 14, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
- Time Frame
- September 2026
- Access Criteria
- When the article is published
Patient characteristics and analysed results